Kyoung Sik Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kyoung Sik Park has a total of 163 co-authors. Here are the top co-authors by number of shared publications:
Jung-Hyun Yang
Department of Surgery, Konkuk University School of Medicine, Seoul, South Korea
8 shared publicationsYoung Bum Yoo
Konkuk University, School of Medicine, Seoul, South Korea
6 shared publications- Ik Jin Yun
Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
5 shared publications - TongYi Jin
Department of Surgery, Konkuk University School of Medicine, Seoul, Korea
5 shared publications - Won Seo Park
Department of Surgery, Kyung Hee University School of Medicine, Seoul, Korea
5 shared publications - Sang Eun Nam
Department of Surgery, Konkuk University School of Medicine, Seoul, Korea
4 shared publications
Latest Publications
- Open Access
- 28 February 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (1) , 174-184
A Comparative Evaluation of Three Time-to-Event Models Predicting 5-Year Osteoporosis Risk in Thyroid Cancer Survivors: A Nationwide Cohort Study
Background: Osteoporosis is a common complication among thyroid cancer survivors; however, predictive tools for this condition remain inadequate. This study aimed to develop time-to-event prediction models for assessing osteoporosis risk in thyroid cancer patients.Methods: Using the Korean National Health Insurance Service claims database, we identified 3,089 patients newly diagnosed with thyroid cancer between 2004 and 2014. Patients were randomly divided into training and test datasets in a 7:3 ratio. Three time-toevent models were constructed: random survival forest, Boruta-Cox proportional hazards, and least absolute shrinkage and selection operator (LASSO)-penalized Cox models, with feature selection and five-fold cross-validation. Model performance was evaluated using time-dependent area under the curve, Harrell’s concordance index (C-index), and risk stratification analysis.Results: Among thyroid cancer survivors with a median follow-up of 4.2 years, the 5-year cumulative incidence of osteoporosis was 21%. The Boruta-Cox proportional hazards model achieved the highest C-index of 0.72 (95% confidence interval [CI], 0.68 to 0.75), outperforming the random survival forest (0.68 [95% CI, 0.65 to 0.71]) and the LASSO-penalized Cox model (0.64 [95% CI, 0.61 to 0.68]). Risk stratification analysis showed that all three models significantly distinguished between low- and high-risk groups (P<0.001).Conclusion: This study constructed well-performing prediction models for estimating osteoporosis risk in thyroid cancer survivors, demonstrating their utility in risk stratification.
- 28 February 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (1) , 174-184
Open AccessA Comparative Evaluation of Three Time-to-Event Models Predicting 5-Year Osteoporosis Risk in Thyroid Cancer Survivors: A Nationwide Cohort Study
Background: Osteoporosis is a common complication among thyroid cancer survivors; however, predictive tools for this condition remain inadequate. This study aimed to develop time-to-event prediction models for assessing osteoporosis risk in thyroid cancer patients.Methods: Using the Korean National Health Insurance Service claims database, we identified 3,089 patients newly diagnosed with thyroid cancer between 2004 and 2014. Patients were randomly divided into training and test datasets in a 7:3 ratio. Three time-toevent models were constructed: random survival forest, Boruta-Cox proportional hazards, and least absolute shrinkage and selection operator (LASSO)-penalized Cox models, with feature selection and five-fold cross-validation. Model performance was evaluated using time-dependent area under the curve, Harrell’s concordance index (C-index), and risk stratification analysis.Results: Among thyroid cancer survivors with a median follow-up of 4.2 years, the 5-year cumulative incidence of osteoporosis was 21%. The Boruta-Cox proportional hazards model achieved the highest C-index of 0.72 (95% confidence interval [CI], 0.68 to 0.75), outperforming the random survival forest (0.68 [95% CI, 0.65 to 0.71]) and the LASSO-penalized Cox model (0.64 [95% CI, 0.61 to 0.68]). Risk stratification analysis showed that all three models significantly distinguished between low- and high-risk groups (P<0.001).Conclusion: This study constructed well-performing prediction models for estimating osteoporosis risk in thyroid cancer survivors, demonstrating their utility in risk stratification.
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (4) , 203-207
The impact of the media coverage on the thyroid cancer overdiagnosis issue concerning the surgical trends in South Korea, 2012–2017: a retrospective multicenter cohort study
Lee JH, et al. Ann Surg Treat Res. 2026 Oct;111(4):203-207. https://doi.org/10.4174/astr.2026.111.4.203
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (4) , 203-207
Open AccessThe impact of the media coverage on the thyroid cancer overdiagnosis issue concerning the surgical trends in South Korea, 2012–2017: a retrospective multicenter cohort study
Lee JH, et al. Ann Surg Treat Res. 2026 Oct;111(4):203-207. https://doi.org/10.4174/astr.2026.111.4.203
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (2) , 84-91
Increased risk of osteoporosis among thyroid cancer survivors: the influence of postoperative levothyroxine therapy in a nationwide cohort study
Our study aimed to assess whether individuals diagnosed with thyroid cancer face an elevated risk of osteoporosis compared to control subjects in a large-scale study. Additionally, we intended to identify potential risk factors associated with osteoporosis in patients with thyroid cancer. We used the National Health Insurance Service-National Sample Cohort of South Korea. We included 1,313 patients diagnosed with thyroid cancer and 3,939 control subjects without cancer. Following propensity score matching at a 1:3 ratio, Cox proportional hazards regression and stratification analyses were used to estimate the risk of osteoporosis in patients with thyroid cancer, incorporating multivariate adjustments. A restricted cubic spline model was employed to evaluate dose-response relationships. Thyroid cancer patients exhibited a higher likelihood of developing osteoporosis than the control group (hazard ratio [HR], 6.59; P < 0.001). In the stratification analyses, younger thyroid cancer patients, females, and those who did not have dyslipidemia were more susceptible to osteoporosis than their counterparts in the control group. Furthermore, the administration of levothyroxine has been linked to an elevated risk of osteoporosis (HR, 2.33; P = 0.044). A restricted cubic spline analysis demonstrated a significant overall association between exposure and outcome (P for total = 0.007, P for nonlinear = 0.573), indicating an essentially linear relationship. Thyroid cancer patients showed a higher risk of osteoporosis compared to matched controls. Stratified analyses suggested that levothyroxine therapy may be a risk factor for osteoporosis. These findings highlight the importance of individualized treatment approaches.
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (2) , 84-91
Open AccessIncreased risk of osteoporosis among thyroid cancer survivors: the influence of postoperative levothyroxine therapy in a nationwide cohort study
Our study aimed to assess whether individuals diagnosed with thyroid cancer face an elevated risk of osteoporosis compared to control subjects in a large-scale study. Additionally, we intended to identify potential risk factors associated with osteoporosis in patients with thyroid cancer. We used the National Health Insurance Service-National Sample Cohort of South Korea. We included 1,313 patients diagnosed with thyroid cancer and 3,939 control subjects without cancer. Following propensity score matching at a 1:3 ratio, Cox proportional hazards regression and stratification analyses were used to estimate the risk of osteoporosis in patients with thyroid cancer, incorporating multivariate adjustments. A restricted cubic spline model was employed to evaluate dose-response relationships. Thyroid cancer patients exhibited a higher likelihood of developing osteoporosis than the control group (hazard ratio [HR], 6.59; P < 0.001). In the stratification analyses, younger thyroid cancer patients, females, and those who did not have dyslipidemia were more susceptible to osteoporosis than their counterparts in the control group. Furthermore, the administration of levothyroxine has been linked to an elevated risk of osteoporosis (HR, 2.33; P = 0.044). A restricted cubic spline analysis demonstrated a significant overall association between exposure and outcome (P for total = 0.007, P for nonlinear = 0.573), indicating an essentially linear relationship. Thyroid cancer patients showed a higher risk of osteoporosis compared to matched controls. Stratified analyses suggested that levothyroxine therapy may be a risk factor for osteoporosis. These findings highlight the importance of individualized treatment approaches.
- Open Access
- 12 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2250
Sex-Stratified Prediction Models for 5-Year Nonalcoholic Fatty Liver Disease Risk in Thyroid Cancer Patients: A Nationwide Cohort Study
Background/Objectives: Nonalcoholic fatty liver disease (NAFLD) is a significant complication among survivors of thyroid cancer; however, existing prediction models for NAFLD remain inadequate. Our objective was to develop survival prediction models for 5-year risk of NAFLD in patients diagnosed with thyroid cancer. Methods: Utilizing the Korean National Health Insurance Service claims database, we selected 3644 post-thyroidectomy patients with thyroid cancer between 2004 and 2014. Following a 7:3 stratified division into training and test datasets, we developed sex-stratified survival models using random survival forest (RSF) and Cox proportional hazards regression (Cox). The evaluation of prediction models was performed using Harrell’s concordance index (C-index), time-dependent area under the curve (AUC), and risk stratification analysis. Results: In the female cohort, the Cox model exhibited a superior C-index of 0.67 (95% CI 0.61–0.72), surpassing the RSF model, which had a C-index of 0.62 (95% CI 0.57–0.68). Notably, age-stratified Cox models for females demonstrated enhanced performance compared to the unstratified female Cox model. Conversely, male-specific models did not show significant performance in NAFLD. Risk stratification analysis revealed that the female-specific models effectively categorized patients into low- and high-risk groups, with statistical significance (p < 0.001). Conclusions: This study constructed well-performing time-to-event prediction models for NAFLD of female patients with thyroid cancer, which is significant in risk stratification.
- 12 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2250
Open AccessSex-Stratified Prediction Models for 5-Year Nonalcoholic Fatty Liver Disease Risk in Thyroid Cancer Patients: A Nationwide Cohort Study
Background/Objectives: Nonalcoholic fatty liver disease (NAFLD) is a significant complication among survivors of thyroid cancer; however, existing prediction models for NAFLD remain inadequate. Our objective was to develop survival prediction models for 5-year risk of NAFLD in patients diagnosed with thyroid cancer. Methods: Utilizing the Korean National Health Insurance Service claims database, we selected 3644 post-thyroidectomy patients with thyroid cancer between 2004 and 2014. Following a 7:3 stratified division into training and test datasets, we developed sex-stratified survival models using random survival forest (RSF) and Cox proportional hazards regression (Cox). The evaluation of prediction models was performed using Harrell’s concordance index (C-index), time-dependent area under the curve (AUC), and risk stratification analysis. Results: In the female cohort, the Cox model exhibited a superior C-index of 0.67 (95% CI 0.61–0.72), surpassing the RSF model, which had a C-index of 0.62 (95% CI 0.57–0.68). Notably, age-stratified Cox models for females demonstrated enhanced performance compared to the unstratified female Cox model. Conversely, male-specific models did not show significant performance in NAFLD. Risk stratification analysis revealed that the female-specific models effectively categorized patients into low- and high-risk groups, with statistical significance (p < 0.001). Conclusions: This study constructed well-performing time-to-event prediction models for NAFLD of female patients with thyroid cancer, which is significant in risk stratification.
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study
Background: Given that patients with thyroid cancer experience several metabolic disorders, it is inferred that these patients have an elevated risk of non-alcoholic fatty liver disease (NAFLD). However, large-scale studies on this topic are lacking. This study aimed to elucidate the association between thyroid cancer and NAFLD. Methods: We used data from the Korean National Health Insurance Service Sample Cohort. A total of 1,407 patients with thyroid cancer and 4,221 matched controls were included following the exclusion process and propensity score matching at a ratio of 1:3. We analyzed hazard ratio, risk factors for NAFLD. Results: The study revealed an increased risk of NAFLD (HR 2.28; 95% CI 1.69–3.10; P < 0.001) in patients with thyroid cancer. Thyroid cancer patients exhibited a higher risk of NAFLD when they had no regular exercise (HR 2.41; 95% CI 1.75–3.32). Moreover, body mass index (BMI) and levothyroxine dosage have been identified as potential critical factors for the development of NAFLD in patients with thyroid cancer. Conclusion: The incidence rate of NAFLD was higher in patients with thyroid cancer than in the controls. Healthcare professionals should consider regular physical activity, BMI, and cumulative levothyroxine dosage when managing patients with thyroid cancer to mitigate the incidence of NAFLD.
- 1 July 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Open AccessIncreased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study
Background: Given that patients with thyroid cancer experience several metabolic disorders, it is inferred that these patients have an elevated risk of non-alcoholic fatty liver disease (NAFLD). However, large-scale studies on this topic are lacking. This study aimed to elucidate the association between thyroid cancer and NAFLD. Methods: We used data from the Korean National Health Insurance Service Sample Cohort. A total of 1,407 patients with thyroid cancer and 4,221 matched controls were included following the exclusion process and propensity score matching at a ratio of 1:3. We analyzed hazard ratio, risk factors for NAFLD. Results: The study revealed an increased risk of NAFLD (HR 2.28; 95% CI 1.69–3.10; P < 0.001) in patients with thyroid cancer. Thyroid cancer patients exhibited a higher risk of NAFLD when they had no regular exercise (HR 2.41; 95% CI 1.75–3.32). Moreover, body mass index (BMI) and levothyroxine dosage have been identified as potential critical factors for the development of NAFLD in patients with thyroid cancer. Conclusion: The incidence rate of NAFLD was higher in patients with thyroid cancer than in the controls. Healthcare professionals should consider regular physical activity, BMI, and cumulative levothyroxine dosage when managing patients with thyroid cancer to mitigate the incidence of NAFLD.
- Open Access
The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
Gene mutations in PIK3CA, the catalytic subunit of phosphoinositide 3-kinases, are significantly associated with prognosis in breast cancer. This association suggests that breast cancer patients with PIK3CA mutations should receive PIK3CA mutant-specific treatment. This review aimed to investigate novel treatments for PIK3CA-mutant breast cancer. This study investigated the effects of PIK3CA mutations in breast cancer with respect to gene ontology and the PI3K/AKT/mTOR pathway. Subsequently, we comprehensively examined all clinical trials that targeted breast cancer patients with PIK3CA mutations. Finally, this review explored the potential of a new treatment for noncoding RNA.
Open AccessThe Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
Gene mutations in PIK3CA, the catalytic subunit of phosphoinositide 3-kinases, are significantly associated with prognosis in breast cancer. This association suggests that breast cancer patients with PIK3CA mutations should receive PIK3CA mutant-specific treatment. This review aimed to investigate novel treatments for PIK3CA-mutant breast cancer. This study investigated the effects of PIK3CA mutations in breast cancer with respect to gene ontology and the PI3K/AKT/mTOR pathway. Subsequently, we comprehensively examined all clinical trials that targeted breast cancer patients with PIK3CA mutations. Finally, this review explored the potential of a new treatment for noncoding RNA.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 25 (1) , 1-12
Advancements and Clinical Strategies in Parathyroid Transplantation: A Comprehensive Review
Hwang SA, et al. J Endocr Surg. 2025 Mar;25(1):1-12. https://doi.org/10.16956/jes.2025.25.1.1
- 1 January 2025
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 25 (1) , 1-12
Open AccessAdvancements and Clinical Strategies in Parathyroid Transplantation: A Comprehensive Review
Hwang SA, et al. J Endocr Surg. 2025 Mar;25(1):1-12. https://doi.org/10.16956/jes.2025.25.1.1
- Open Access
- 12 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 172
PET/MRI and Novel Targets for Breast Cancer
Breast cancer, with its global prevalence and impact on women’s health, necessitates effective early detection and accurate staging for optimal patient outcomes. Traditional imaging modalities such as mammography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging (MRI) play crucial roles in local-regional assessment, while bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) aid in evaluating distant metastasis. Despite the proven utility of 18F-FDG PET/CT in various cancers, its limitations in breast cancer, such as high false-negative rates for small and low-grade tumors, have driven exploration into novel targets for PET radiotracers, including estrogen receptor, human epidermal growth factor receptor-2, fibroblast activation protein, and hypoxia. The advent of PET/MRI, which combines metabolic PET information with high anatomical detail from MRI, has emerged as a promising tool for breast cancer diagnosis, staging, treatment response assessment, and restaging. Technical advancements including the integration of PET and MRI, considerations in patient preparation, and optimized imaging protocols contribute to the success of dedicated breast and whole-body PET/MRI. This comprehensive review offers the current technical aspects and clinical applications of PET/MRI for breast cancer. Additionally, novel targets in breast cancer for PET radiotracers beyond glucose metabolism are explored.
- 12 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 172
Open AccessPET/MRI and Novel Targets for Breast Cancer
Breast cancer, with its global prevalence and impact on women’s health, necessitates effective early detection and accurate staging for optimal patient outcomes. Traditional imaging modalities such as mammography, ultrasound, and dynamic contrast-enhanced magnetic resonance imaging (MRI) play crucial roles in local-regional assessment, while bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) aid in evaluating distant metastasis. Despite the proven utility of 18F-FDG PET/CT in various cancers, its limitations in breast cancer, such as high false-negative rates for small and low-grade tumors, have driven exploration into novel targets for PET radiotracers, including estrogen receptor, human epidermal growth factor receptor-2, fibroblast activation protein, and hypoxia. The advent of PET/MRI, which combines metabolic PET information with high anatomical detail from MRI, has emerged as a promising tool for breast cancer diagnosis, staging, treatment response assessment, and restaging. Technical advancements including the integration of PET and MRI, considerations in patient preparation, and optimized imaging protocols contribute to the success of dedicated breast and whole-body PET/MRI. This comprehensive review offers the current technical aspects and clinical applications of PET/MRI for breast cancer. Additionally, novel targets in breast cancer for PET radiotracers beyond glucose metabolism are explored.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 24 (2) , 31-38
Changes in the Trend of Thyroid Cancer Epidemiology According to South Korean Nationwide Database, 1999–2020
Park D, et al. J Endocr Surg. 2024 Jun;24(2):31-38. https://doi.org/10.16956/jes.2024.24.2.31
- 1 January 2024
- Published by XMLink in Journal of Endocrine Surgery
- Vol. 24 (2) , 31-38
Open AccessChanges in the Trend of Thyroid Cancer Epidemiology According to South Korean Nationwide Database, 1999–2020
Park D, et al. J Endocr Surg. 2024 Jun;24(2):31-38. https://doi.org/10.16956/jes.2024.24.2.31
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (5) , 263-273
CTLA4 expression profiles and their association with clinical outcomes of breast cancer: a systemic review
Jin T, et al. Ann Surg Treat Res. 2024 May;106(5):263-273. https://doi.org/10.4174/astr.2024.106.5.263
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (5) , 263-273
Open AccessCTLA4 expression profiles and their association with clinical outcomes of breast cancer: a systemic review
Jin T, et al. Ann Surg Treat Res. 2024 May;106(5):263-273. https://doi.org/10.4174/astr.2024.106.5.263